Update Swiss guideline for counselling and testing for predisposition to breast, ovarian, pancreatic and prostate cancer.
Journal
Swiss medical weekly
ISSN: 1424-3997
Titre abrégé: Swiss Med Wkly
Pays: Switzerland
ID NLM: 100970884
Informations de publication
Date de publication:
13 09 2021
13 09 2021
Historique:
entrez:
14
9
2021
pubmed:
15
9
2021
medline:
21
10
2021
Statut:
epublish
Résumé
This paper presents the Swiss guideline for genetic counselling and testing of individuals with an increased probability for carrying mutations in high risk cancer predisposition genes, particularly BRCA1 and BRCA2. It aims to help providers of genetic counselling to identify valuable candidates for testing and serves as a basis for reimbursement claims to Swiss insurance companies.
Identifiants
pubmed: 34519462
doi: 10.4414/SMW.2021.w30038
pii: Swiss Med Wkly. 2021;151:w30038
doi:
pii:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM